Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,617 signal articles · 82 in last 24h · 155,546 total before filter · latest 1h ago
82last 24h
846last 7d
142● bullish (7d)
91● bearish (7d)
214publishers
AllMacro193Earnings105M&A123Regulatory20Product21Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Diamondback Energy Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Diamondback Energy Q2 Earnings Call Highlights

Diamondback Energy (NASDAQ:FANG) said its second-quarter operational performance and view of global oil inventories support a potential path toward low-single-digit organic production growth in 2027, while management emphasized it intends to retain flexibility amid commodity-market volatility. Chie

Cipher Mining Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Cipher Mining Q2 Earnings Call Highlights

Cipher Mining (NASDAQ:CIFR) said its second-quarter 2026 business update reflected continued progress in its transition toward developing and operating data centers for high-performance computing, or HPC, customers. The company highlighted an accelerated delivery at its Black Pearl campus, an $810 m

Bruker Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Bruker Q2 Earnings Call Highlights

Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue

Timken (TKR) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks53d agoneutral
Timken (TKR) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Timken (TKR) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Pfizer raises revenue outlook after quarterly earnings top estimates
Proactive53d agoneutral
Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio. The pharmaceutical company reported...

BioNTech Q2 Earnings Call Highlights
MarketBeat53d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt